PL429355A1 - Zastosowanie wodnego ekstraktu z raka pręgowatego - Google Patents
Zastosowanie wodnego ekstraktu z raka pręgowategoInfo
- Publication number
- PL429355A1 PL429355A1 PL429355A PL42935519A PL429355A1 PL 429355 A1 PL429355 A1 PL 429355A1 PL 429355 A PL429355 A PL 429355A PL 42935519 A PL42935519 A PL 42935519A PL 429355 A1 PL429355 A1 PL 429355A1
- Authority
- PL
- Poland
- Prior art keywords
- extract
- spinycheek
- aplication
- crayfish
- aqueous extract
- Prior art date
Links
- 241001135934 Faxonius limosus Species 0.000 title abstract 2
- 239000006286 aqueous extract Substances 0.000 title abstract 2
- 201000009030 Carcinoma Diseases 0.000 abstract 2
- 239000000284 extract Substances 0.000 abstract 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract 2
- 239000010931 gold Substances 0.000 abstract 2
- 229910052737 gold Inorganic materials 0.000 abstract 2
- 239000002105 nanoparticle Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000084 colloidal system Substances 0.000 abstract 1
- 210000002950 fibroblast Anatomy 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/82—Undefined extracts from animals from invertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Przedmiotem wynalazku jest zastosowanie liofilizowanego ekstraktu wodnego z całego raka pręgowatego (Orconectes limosus), ewentualnie z dodatkiem nanocząstek złota, jako środka stymulującego wzrost komórek fibroblastów w hodowli in vitro. Zgodnie z wynalazkiem stosuje się wodny roztwór ekstraktu z raka pręgowatego zawierający liofilizowany ekstrakt w ilości od 100 mg do 1000 mg w 1 dm3 wody, do którego ewentualnie dodaje się koloid zawierający od 10 do 100 mg nanocząstek złota w 1 dm3 wody.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL429355A PL237977B1 (pl) | 2019-03-21 | 2019-03-21 | Zastosowanie liofilizowanego ekstraktu wodnego z całego raka pręgowatego |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL429355A PL237977B1 (pl) | 2019-03-21 | 2019-03-21 | Zastosowanie liofilizowanego ekstraktu wodnego z całego raka pręgowatego |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL429355A1 true PL429355A1 (pl) | 2020-10-05 |
| PL237977B1 PL237977B1 (pl) | 2021-06-14 |
Family
ID=72669293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL429355A PL237977B1 (pl) | 2019-03-21 | 2019-03-21 | Zastosowanie liofilizowanego ekstraktu wodnego z całego raka pręgowatego |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL237977B1 (pl) |
-
2019
- 2019-03-21 PL PL429355A patent/PL237977B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL237977B1 (pl) | 2021-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019007276A (es) | Composiciones y métodos para mejora o aumento de la producción de ifn tipo i. | |
| IN2015MU00865A (pl) | ||
| MX388893B (es) | Formulaciones de anticuerpos estables acuosas. | |
| ECSP12012298A (es) | Formulaciones de insulina de acción prolongada | |
| IN2012DN04940A (pl) | ||
| MX2011010673A (es) | Formulaciones de nanoparticulas y usos de las mismas. | |
| MY207269A (en) | Aerosolisable formulation | |
| UY36542A (es) | Formulaciones farmacéuticas para anticuerpos anti-tnf-alfa | |
| MX2020007495A (es) | Formulacion de adenovirus del grupo b. | |
| PH12012501402A1 (en) | Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease | |
| FR3065225B1 (fr) | Adjuvants depourvus de cytokines pour milieux de culture cellulaire, notamment pour fecondation in vitro, ou pour la culture de follicules, cellules germinales males ou embryons | |
| MX2022006882A (es) | Formulaciones de anticuerpos anti-cd38 para administracion subcutanea. | |
| MX387008B (es) | Compuestos de alteración de telómero mediada por telomerasa. | |
| MX361642B (es) | Composiciones antisépticas catiónicas. | |
| PL429355A1 (pl) | Zastosowanie wodnego ekstraktu z raka pręgowatego | |
| MX2021012543A (es) | Compuestos de indoles quirales y su uso. | |
| MX2024005649A (es) | Proteinas quimericas basadas en sirp1a y cd40l. | |
| AR108972A1 (es) | Tratamiento de la enfermedad vascular retiniana mediante el uso de células progenitoras | |
| WO2019232474A3 (en) | Compositions and methods for increasing consumption of water in companion animals | |
| MX2021007643A (es) | Composiciones para el cuidado bucal y metodos de uso. | |
| MX2021002516A (es) | Modificaciones de solvente a sustratos prehumedecidos. | |
| FR3061208B1 (fr) | Adjuvants pour milieux de culture cellulaire, notamment pour fecondation in vitro, ou pour la culture de follicules, cellules germinales males ou embryons | |
| TWD206291S (zh) | 吸奶器 | |
| Sheng et al. | Three new species of the genus Notosemus Förster, 1869 (Hymenoptera, Ichneumonidae, Ichneumoninae) from China, with a key to the world species | |
| MY196148A (en) | Microalgal-Based Anti-Cancer Agents And Methods Of Synthesizing The Same |